Science Sparks @ ACTREC
20 January 2025Publications
- 1. Kumar B, Mittal P, Gupta A, Mulani J, Bhajbhuje R, Kannan S, Jain J, Chopra S (2025). Learning curve and proficiency assessment for gynecological brachytherapy amongst radiation oncology trainees in India: Results from a prospective study. Brachytherapy.
- 2. Sundararajan R, Hegde SR, Panda AK, Christie J, Gadewal N, Venkatraman P (2025). Loss of correlated proteasomal subunit expression selectively promotes the 20SHigh state which underlies luminal breast tumorigenicity. Communications Biology. 8(1): 55.
- 3. Singh AG, Sinha S, Shetty R, Joshi P, Nair SV, Chaturvedi P (2025). Impact of Local Extent of Tumor on the Survival Outcomes for Surgically Treated Tongue Cancers. Head Neck.
- 4. Gandhi AK, Chopra S, Rastogi M, Mallick I, Cruz MC, Yasuda K, Sum YY, Nagata Y, Wu HG, Prajogi GB, Kodrat H, Ma M, Nisar A, Chitapanarux I (2025). Multicentric Cross-Sectional Survey to Assess the Variation of Fractionation Strategies Used in the Management of Head and Neck Cancers in the Asian Region (INNOCENCE-ASIA). JCO Global Oncology.
Site of the Week
BloodChIP Xtra is a user-friendly database that facilitates genome-wide exploration and visualization of transcription factor (TF) occupancy and chromatin configuration in rare primary human hematopoietic stem (HSC-MPP) and progenitor (CMP, GMP, MEP) cells and acute myeloid leukemia (AML).
Interesting Reads
Video of the Week
From Synthetic Insights to ‘Au-Naturel’: IL-9 in T- Cell Therapy
Upcoming Events
February 3-5, 2025
At SRM Institute of Science & Technology, Kattankulathur-603203
January 25, 2024
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai -410210
Do You Know?
In 2016, FDA approved a liquid biopsy test, a companion diagnostic test called cobas EGFR Mutation Test v2.
Cancer News
MedicalXpress, 16/01/2025
Researchers found that three types of immune cells needed to be present for the tumor to respond to treatment: fighter cells called T and NK cells, and cells called macrophages, which present flags on their surfaces to highlight a threat to the body...
National Cancer Institute, 14/01/2025
The study showed that several types of cancer cells lacked the enzyme needed to use fructose directly. However, liver cells have the necessary enzyme, called KHK, and used it to convert fructose into fats called lipids...
News-Medical, 13/01/2025
The new test works by detecting two sugars - CA199.STRA and CA19-9 - that are produced by pancreatic cancer cells and escape into the bloodstream. CA19-9 is the current gold-standard biomarker for pancreatic cancer...
© 2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)